Business Wire

CTBC Brand Campaign Gives Gratitude to Employees

30.12.2020 04:25:00 EET | Business Wire | Press release

Share

CTBC Financial Holding Co., Ltd.'s (CTBC Financial Holding) has released a short film titled ‘A simple thank you (如常‧謝謝你)’ on Dec. 28 to express thanks to all the employees for their efforts during the COVID-19 pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005461/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

CTBC Brand Campaign Gives Gratitude to Employees (Photo: Business Wire)

Directed by Hsiao Ya-chuan (蕭雅全) and uses “Thank You” by artist Summer Lei (雷光夏) as background music, the video restores the 91 days where more than 2,600 CTBC employees worked overtime to help 280,000 workers apply for relief loans and completed the workload that would have take two and a half years in just three months.

In response to the impacts of the COVID-19 pandemic, CTBC Financial Holding provides relief loans and has sped up the process through digital financial technology.

The filming team interviewed several employees in the hope to create realistic and detailed script for the film, and the interviewees were already in tears before they even began to talk. During the filming, more than 40 employees impressed director Hsiao with their engagement and dedication.

Chairman Wen Long Yen (顏文隆) of CTBC Financial Holding also participated in the filming this time to express his appreciation and echoed the brand sprit “We are family” with actions.

In 2001, when CTBC Bank launched a new system, thousands of employees worked overtime and sacrificed holiday to spend time with their families to make it happen. To thanks employees for their hard work, CTBC Financial Holding founder Jeffrey Koo (辜濓松) invited notable director Hou Hsiao-hsien (侯孝賢) to make a film, which was released on the New Year’s Eve in 2002, one year after the new system came online.

In 2014, a special video was made when the headquarters of CTBC relocated to CTBC Financial Park in Nangang, Taipei to express the sentiments to the old headquarters in Xinyi District.

This year, the brand campaign ‘Our Ordinary Home’ released in June presents Taiwan’s resilience in the face of the pandemic. The video has been watched more than 12 million times on the Internet.

The full-length video of “Our Ordinary Home, Thank You” is now available on YouTube and Home Run Taiwan’s Facebook fan page.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Public Relations Dept.│CTBC Bank Co., Ltd.
Name: Pamela Chen
Email: pamela.chen@ctbcbank.com
Phone: +886-2-3327-7777 Ext.6724

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 08:30:00 EEST | Press release

SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye